Author | Alice T. Shaw, MD, PhD

Articles

Newer Targeted Agents in NSCLC: ALK Inhibitors

June 13, 2018

Alice Shaw highlights the development and clinical considerations for use of first- and next-generation ALK inhibitors in NSCLC, plus ongoing research.